Dr. Henry Conter is solving the impossible problems in healthcare by re-imagining how all types of people can take control of their care and maximize their experience and outcomes. He is a Strategic Health Care Partner at Hoffmann-La Roche, designing patient-focused healthcare solutions that matter to them. He continues as a practicing medical oncologist/hematologist at William Osler Health System and an adjunct professor at the University of Western Ontario, Schulich School of Medicine & Dentistry. Prior to joining Roche, Dr. Conter has a track record for innovation and excellence in leadership as Medical Director of the Cancer Health System, and Executive Medical Director of Quality, Patient Safety, and Health System integration at Osler. He served as a voting member on the Ontario Steering Committee for Cancer Drugs and a member of the pan-Canadian Oncology Drug Review (pCODR) Expert Review Panel and CADTHs national Pharmacare Advisory Panel as the oncology representative. Previously he served on pCODR’s Economic Guidance Panels and Clinical Guidance Panels. Dr. Conter completed his undergraduate degree in mechanical engineering at the University of Western Ontario in 2007. He graduated from McMaster School of Medicine in 2008. He then went to the University of Alberta where he completed his clinical residency in internal medicine in 2011, and received his MSc in health technology assessment in 2012. He completed his clinical fellowship in medical oncology at the University of Texas M.D. Anderson Cancer Center in Houston Texas, and a Masters in Finance at the University of Houston in 2013

• 

  Advisor in TryCycle Data Systems

  Working Together to “Try” to Break the “Cycle” of addiction, depression, loneliness and other mental health challenges.